Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preclinical pharmacology of the new GLP-1 receptor agonist AVE0010.

× No keyword cloud information.

6 in total

Review 1. Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents.

Authors: Baptist Gallwitz
Journal: Drugs Date: 2011-09-10 Impact factor: 9.546

2. GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors: Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal: Rev Endocr Metab Disord Date: 2014-09 Impact factor: 6.514

Review 3. The evolving place of incretin-based therapies in type 2 diabetes.

Authors: Baptist Gallwitz
Journal: Pediatr Nephrol Date: 2010-02-04 Impact factor: 3.714

Review 4. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.

Authors: Bo Ahrén
Journal: Nat Rev Drug Discov Date: 2009-04-14 Impact factor: 84.694

5. Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus.

Authors: Jason Seewoodhary; Leanne Griffin; Stephen C Bain
Journal: Diabetes Metab Syndr Obes Date: 2010-05-17 Impact factor: 3.168

6. Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies.

Authors: Charles F Shaefer
Journal: Clin Diabetes Date: 2016-04

6 in total